The S&P/ASX 200 Index (ASX: XJO) briefly ticked over 7,300 today for the first time on record. While the big banks and miners were responsible for most of the heavy lifting, these ASX 200 shares have cruised to record all-time highs.
Image source: Getty Images
ASX 200 shares making record all-time highs
ARB Corp Ltd (ASX: ARB)
Australia's largest manufacturer and distributor of 4×4 accessories could be benefitting from some industry tailwinds.
According to Commsec, vehicle sales are bouncing back after COVID-19 induced supply shortages last year. Its report observed that "SUVs and Utes are the wheels of choice, accounting for 8 of the top 10 vehicles sold."
Taking a broader view, Commsec said that new vehicle sales totalled 100,005 in March, up 22.4% from a year ago.
The ARB share price has run ~11% higher from its February record all-time highs of $40.00. Its shares marked an intraday high of $45.63 and are currently fetching $44.54.
Goodman Group (ASX: GMG)
Goodman has pulled ahead of other ASX-listed REITs today. After an 8-month lull where its share price hovered around the $17 to $19 level, its shave have broke out to record all-time highs this month.
The Goodman share price is up ~5% this month, scoring an intraday record all-time high of $20.77. Its shares have pulled back slightly, currently trading at $20.53.
The last time we heard from Goodman was during its third-quarter update on 7 May. This update included the REIT reaffirming its FY21 guidance of $1.2 billion in operating profit, representing an earnings per share growth of 12% on FY20.
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price is another ASX 200 share breaking out. Its shares marked an intraday record all-time of $49.81 on Monday and are currently trading at $48.90.
The company's bullish run has been supported by its continued stream of positive announcements. On 13 May, the company announced an 8-year contract with The University of Vermont Health Network Inc, expected to generate $14 million in revenue. Then on 3 June, the company signed a multi-year research collaboration agreement with Mayo Clinic.
